Breast Cancer Risk Appears to Be Higher in Women Who Have Had Babies, Study Shows
Women who have given birth have a higher risk of developing breast cancer, a risk that can persist for more than 20 years after ... Read more
Updates
-
-
Phase 1b/2 Trial Testing Rebastinib/Chemo Combo in Advanced Cancer Patients Begins
A Phase 1b/2 clinical trial testing rebastinib, in combination with the chemotherapy medication carboplatin, in adults with breast cancer and patients with other ... Read more -
Partial Breast Radiation Therapy May Effectively Prevent Cancer Relapse, Trial Shows
Accelerated partial breast irradiation, a therapy that delivers higher doses of radiation over a shorter period of time and targets only the part of ... Read more -
FDA OKs Phase 2 Trial of AE37-Keytruda Combo in Metastatic Triple-negative Breast Cancer
Generex Biotechnology is planning a Phase 2 trial to test a combination of its AE37 peptide vaccine and Keytruda (pembrolizumab) in patients with advanced triple-negative breast cancer, after ... Read more -
Short, Striped, and Revealing: The Worst New Year’s Eve Dress Ever
On New Year’s Eve, I put on a gown. It was a blue- and white-striped number, short, tied at the waist, and opened in ... Read more
-
Circulating Tumor Cell Numbers May Help Decide Best Therapy for Metastatic Breast Cancer, Phase 3 Trial Shows
The number of circulating tumor cells (CTCs) could help doctors choose between hormone therapy ... -
Phase 3 Trial of Sacituzumab Govitecan Recruiting Triple-negative Breast Cancer Patients
A Phase 3 trial is recruiting participants to examine the effects of sacituzumab govitecan ... -
Top 10 Breast Cancer Articles of 2018
Breast Cancer News brought you daily coverage of important discoveries, treatment developments, clinical trials, ... -
Breast Cancer Stole My Bling
I have skinny wrists, so I’ve never gotten into the habit of wearing bracelets. ... -
Enrollment Complete in Phase 2 Trial of NeuVax-Herceptin for HER2-Positive, High-Risk Breast Cancer
The investigator-sponsored trial studying a combination of NeuVax (nelipepimut-S, NPS) and Herceptin (trastuzumab) as a ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU
News
The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase 3 clinical trial. Approximately half of women in ... Read more